preferential reactivity by melanoma patients was detected towards only 2 of the 6 melanoma cell lines tested -- 53 % of 55 melanoma sera reactive to libr compared with 28 % of 79 sera from patients with other tumours and 17 % of 29 normal sera ( p less than 0.05 ) ;
C1513095
melanoma cell
C0025202
sera